Stem cell technology in breast cancer: current status and potential applications
Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the t...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c5800a4b3ad4ccb810a8a42323ca84c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3c5800a4b3ad4ccb810a8a42323ca84c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3c5800a4b3ad4ccb810a8a42323ca84c2021-12-02T00:13:22ZStem cell technology in breast cancer: current status and potential applications1178-6957https://doaj.org/article/3c5800a4b3ad4ccb810a8a42323ca84c2016-04-01T00:00:00Zhttps://www.dovepress.com/stem-cell-technology-in-breast-cancer-current-status-and-potential-app-peer-reviewed-article-SCCAAhttps://doaj.org/toc/1178-6957Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs). BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. Keywords: breast cancer stem cells, cancer stem cell heterogeneity, targeting cancer stem cells, circulating tumor cells, stem cell technologyChiotaki RPolioudaki HTheodoropoulos PADove Medical PressarticleBreast cancer stem cellscancer stem cell heterogeneitytargeting cancer stem cellscirculating tumor cellsstem cell technologyCytologyQH573-671ENStem Cells and Cloning: Advances and Applications, Vol 2016, Iss Issue 1, Pp 17-29 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Breast cancer stem cells cancer stem cell heterogeneity targeting cancer stem cells circulating tumor cells stem cell technology Cytology QH573-671 |
spellingShingle |
Breast cancer stem cells cancer stem cell heterogeneity targeting cancer stem cells circulating tumor cells stem cell technology Cytology QH573-671 Chiotaki R Polioudaki H Theodoropoulos PA Stem cell technology in breast cancer: current status and potential applications |
description |
Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs). BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. Keywords: breast cancer stem cells, cancer stem cell heterogeneity, targeting cancer stem cells, circulating tumor cells, stem cell technology |
format |
article |
author |
Chiotaki R Polioudaki H Theodoropoulos PA |
author_facet |
Chiotaki R Polioudaki H Theodoropoulos PA |
author_sort |
Chiotaki R |
title |
Stem cell technology in breast cancer: current status and potential applications |
title_short |
Stem cell technology in breast cancer: current status and potential applications |
title_full |
Stem cell technology in breast cancer: current status and potential applications |
title_fullStr |
Stem cell technology in breast cancer: current status and potential applications |
title_full_unstemmed |
Stem cell technology in breast cancer: current status and potential applications |
title_sort |
stem cell technology in breast cancer: current status and potential applications |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/3c5800a4b3ad4ccb810a8a42323ca84c |
work_keys_str_mv |
AT chiotakir stemcelltechnologyinbreastcancercurrentstatusandpotentialapplications AT polioudakih stemcelltechnologyinbreastcancercurrentstatusandpotentialapplications AT theodoropoulospa stemcelltechnologyinbreastcancercurrentstatusandpotentialapplications |
_version_ |
1718403857407541248 |